Background/Aims: Recent data suggest that tumors of the right and left colon should be distinguished as they differ in clinical and molecular characteristics. Methods: A total of 1,319 patients who underwent surgical resection for colon cancer (CC) were investigated. Tumors between the ileocecal valve and the hepatic flexure were classified as right CC (RCC), tumors between the splenic flexure and the rectum as left CC (LCC). Results: RCC revealed a higher cause-specific mortality risk (hazard ratio 1.36, 95% CI 1.10-1.68, p = 0.005) and lower 5-year cause-specific (RCC 64.9%, 95% CI 60.4-69.4, LCC 70.7%, 95% CI 67.2-74.2, p = 0.032) and disease-free (RCC 56.0%, 95% CI 51.5-60.5, LCC 59.9%, 95% CI 56.2-63.6, p = 0.025) survival rates. RCCs were more often microsatellite instable (RCC 37.2%, LCC 13.0%, p < 0.001) and more often showed KRAS (RCC 42.5%, LCC 18.9%, p = 0.001) and BRAF mutations (RCC 26.6%, LCC 3.2%, p < 0.001). Conclusion: RCC and LCC differ significantly regarding clinical, histopathological and molecular genetic features and can be considered as distinct entities. The reduced prognosis of RCC may be caused by higher rates of microsatellite instability, KRAS and BRAF mutations.

Keywords:
Prognosis, Colon cancer, Location, Left, Right
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2.
Bufill JA: Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-788.
3.
Iacopetta B: Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-408.
4.
Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H; Colon/Rectum Carcinomas (Primary Tumor) Study Group: Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53:57-64.
5.
Price TJ, Beeke C, Ullah S, Padbury R, Maddern G, Roder D, Townsend AR, Moore J, Roy A, Tomita Y, Karapetis C: Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer 2015;121:830-835.
6.
Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK: Is right-sided colon cancer different to left-sided colorectal cancer? - a systematic review. Eur J Surg Oncol 2015;41:300-308.
7.
Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, Smith MA: Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results - medicare data. J Clin Oncol 2011;29:4401-4409.
8.
Benedix F, Meyer F, Kube R, Gastinger I, Lippert H: [Right- and left-sided colonic cancer - different tumour entities]. Zentralbl Chir 2010;135:312-317.
9.
Arvelo F, Sojo F, Cotte C: Biology of colorectal cancer. Ecancermedicalscience 2015;9:520.
10.
Bauer VP, Papaconstantinou HT: Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg 2008;21:273-279.
11.
Noffsinger AE: Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009;4:343-364.
12.
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
13.
Cucino C, Buchner AM, Sonnenberg A: Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002;45:1035-1040.
14.
Rabeneck L, Davila JA, El-Serag HB: Is there a true ‘shift' to the right colon in the incidence of colorectal cancer? Am J Gastroenterol 2003;98:1400-1409.
15.
Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N: Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 2008;15:2388-2394.
16.
Nitsche U, Zimmermann A, Späth C, Müller T, Maak M, Schuster T, Slotta-Huspenina J, Käser SA, Michalski CW, Janssen KP, Friess H, Rosenberg R, Bader FG: Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg 2013;258:775-782; discussion 782-783.
17.
Ploenes T, Börner N, Kirkpatrick CJ, Heintz A: Neuroendocrine tumour, mucinous adenocarcinoma and signet-ring cell carcinoma of the appendix: three cases and review of literature. Indian J Surg 2013;75(suppl 1):299-302.
18.
Bosman FT, Carneiro F, Hruban RH, Theise ND; World Health Organization; International Agency for Research on Cancer: WHO Classification of Tumours of the Digestive System, ed 4. Lyon, International Agency for Research on Cancer, 2010.
19.
Sobin LH, Gospodarowicz MK, Wittekind C; International Union against Cancer: TNM Classification of Malignant Tumours, ed 7. Chichester, West Sussex, Hoboken, Wiley-Blackwell, 2010.
20.
Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP: Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg 2012;256:763-771; discussion 771.
21.
Benedix F, Schmidt U, Mroczkowski P, Gastinger I, Lippert H, Kube R; Study Group ‘Colon/Rectum Carcinoma (Primary Tumor)': Colon carcinoma - classification into right and left sided cancer or according to colonic subsite? - analysis of 29,568 patients. Eur J Surg Oncol 2011;37:134-139.
22.
Saltzstein SL, Behling CA: Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California cancer registry. J Clin Gastroenterol 2007;41:173-177.
23.
Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT: Erbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005;207:53-60.
24.
Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B: Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001;44:364-372; discussion 372-373.
25.
Reifferscheid M, Fass J, Hartung R, Mittermayer C: [Special aspects of right colon cancer]. Langenbecks Arch Chir 1987;371:193-200.
26.
Verhulst J, Ferdinande L, Demetter P, Ceelen W: Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol 2012;65:381-388.
27.
Gao P, Song YX, Xu YY, Sun Z, Sun JX, Xu HM, Wang ZN: Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases. Histopathology 2013;63:603-615.
28.
Sideris M, Papagrigoriadis S: Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. Anticancer Res 2014;34:2061-2068.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.